PHYTOMEDICINE-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2204456, encodeId=69602204456e9, content=偏重的研究方向：天然产物;炎症 经验分享：2023.11投稿； 2024.02.03大修，五个审稿人，审稿人意见不多，编辑给了很多意见，给二十四天，补实验，申请延期一个月修回； 2023.03.26修回； 2023.05.08 decision in process 2023.05.09 accept 2023.05.11 proof. 从投稿到接收发表花了6个月，一审花了接近3个月，杂志要求严格，意见比较中肯，要求提供全膜WB条带（目的条带与内参出自同一条膜），中间因为一些琐事耽搁，2个月后修回，返修后编辑和审稿人效率很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67c06520855, createdName=ms8000001534909283, createdTime=Mon May 13 15:59:16 CST 2024, time=2024-05-13, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2182208, encodeId=314b21822083a, content=偏重的研究方向：中药;心血管 经验分享：请问大家，投稿半个月，状态一直是Submitted to Journal，这种情况正常吗，需要发邮件问一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad4c5114631, createdName=14621ac1m87(暂无昵称), createdTime=Wed Jan 17 15:56:01 CST 2024, time=2024-01-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2195245, encodeId=5a9d2195245ff, content=1.02投稿，现在还在under review...一点消息无。等的心焦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26465474991, createdName=ms2000000315947498, createdTime=Mon Mar 25 16:02:09 CST 2024, time=2024-03-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2177803, encodeId=19a121e7803be, content=让我修了两轮的格式和图片 12.25 submitted to journal 12.26 under editor assessment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240101/570c45f5d7f2451da2e0a51a7b25b479/824b9aa7cdc24982879c3db6cbeb3798.jpg, createdBy=a3422257516, createdName=samtol, createdTime=Thu Dec 28 15:41:53 CST 2023, time=2023-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2203719, encodeId=faec2203e1952, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：单体;药理;胃肠疾病 经验分享：怎么办呢，在编辑手里放了1个多月，现在变成Reviewer invited都十天了，怎么办啊，好想写催稿信，但是又不敢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0de95698009, createdName=ms1000000847212667, createdTime=Thu May 09 17:46:13 CST 2024, time=2024-05-09, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2204148, encodeId=89c5220414846, content=请问各位老师这家接受非邀稿的综述吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=009a8811870, createdName=ms1000000556586108, createdTime=Sat May 11 20:56:37 CST 2024, time=2024-05-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2204018, encodeId=f930220401846, content=有人的editor是暨南大学何教授的吗？她申稿一般很慢吗？已经一周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sat May 11 07:59:44 CST 2024, time=2024-05-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2203518, encodeId=279b2203518d9, content=请问有遇到过editor assessment这一步开始邮件说是分配给主编，之后又分配给副主编的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Wed May 08 19:41:40 CST 2024, time=2024-05-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2190439, encodeId=ddf6219043910, content=想问一下各位大佬，最后投稿前生成的pdf里图片特别不清晰，但是下载下来又是清晰的，这应该怎么搞呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=737c9183844, createdName=ms2000002053337250, createdTime=Fri Mar 01 16:28:28 CST 2024, time=2024-03-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1237955, encodeId=4429123e9555f, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：中药药理;中药复方 经验分享：5.30投稿 5.31要求提供缩略词，补充后当晚提交了 6.6 under review 6.22 Required Reviews Completed 6.26 revise 主编+6个审稿专家，加起来50多个问题，审稿意见非常细节，很注重创新性。还好整体评价比较积极，对文章大框架没什么意见，只给了我3周修改，我还补了一点实验，最后几天写回复写到怀疑人生…… 7.14 summit 7.15 Under Editor Assessment 7.24 under review 8.2 Required Reviews Completed 8.3 Decision in Process 8.4 accepted 8.6 Proof 感谢主编和外审专家们！第一次投sci，好多地方都不清楚，每天都快把论坛翻烂了……还好最后顺利接收，写一点我在翻帖子时大家提问多的事情吧：1.Author Agreement：这个在爱思唯尔投稿作者须知那里有个链接能下载，有点不太好找。2.western结果：revise时要求提供原始未裁剪的膜，这个前期做实验的时候需要注意下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=feb46571516, createdName=msyukira, createdTime=Wed Aug 10 23:59:55 CST 2022, time=2022-08-10, status=1, ipAttribution=)]

2024-05-13 ms8000001534909283 来自吉林省

偏重的研究方向：天然产物;炎症
经验分享：2023.11投稿；
2024.02.03大修，五个审稿人，审稿人意见不多，编辑给了很多意见，给二十四天，补实验，申请延期一个月修回；
2023.03.26修回；
2023.05.08 decision in process
2023.05.09 accept
2023.05.11 proof.
从投稿到接收发表花了6个月，一审花了接近3个月，杂志要求严格，意见比较中肯，要求提供全膜WB条带（目的条带与内参出自同一条膜），中间因为一些琐事耽搁，2个月后修回，返修后编辑和审稿人效率很高。

0 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2204456, encodeId=69602204456e9, content=偏重的研究方向：天然产物;炎症 经验分享：2023.11投稿； 2024.02.03大修，五个审稿人，审稿人意见不多，编辑给了很多意见，给二十四天，补实验，申请延期一个月修回； 2023.03.26修回； 2023.05.08 decision in process 2023.05.09 accept 2023.05.11 proof. 从投稿到接收发表花了6个月，一审花了接近3个月，杂志要求严格，意见比较中肯，要求提供全膜WB条带（目的条带与内参出自同一条膜），中间因为一些琐事耽搁，2个月后修回，返修后编辑和审稿人效率很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67c06520855, createdName=ms8000001534909283, createdTime=Mon May 13 15:59:16 CST 2024, time=2024-05-13, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2182208, encodeId=314b21822083a, content=偏重的研究方向：中药;心血管 经验分享：请问大家，投稿半个月，状态一直是Submitted to Journal，这种情况正常吗，需要发邮件问一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad4c5114631, createdName=14621ac1m87(暂无昵称), createdTime=Wed Jan 17 15:56:01 CST 2024, time=2024-01-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2195245, encodeId=5a9d2195245ff, content=1.02投稿，现在还在under review...一点消息无。等的心焦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26465474991, createdName=ms2000000315947498, createdTime=Mon Mar 25 16:02:09 CST 2024, time=2024-03-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2177803, encodeId=19a121e7803be, content=让我修了两轮的格式和图片 12.25 submitted to journal 12.26 under editor assessment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240101/570c45f5d7f2451da2e0a51a7b25b479/824b9aa7cdc24982879c3db6cbeb3798.jpg, createdBy=a3422257516, createdName=samtol, createdTime=Thu Dec 28 15:41:53 CST 2023, time=2023-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2203719, encodeId=faec2203e1952, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：单体;药理;胃肠疾病 经验分享：怎么办呢，在编辑手里放了1个多月，现在变成Reviewer invited都十天了，怎么办啊，好想写催稿信，但是又不敢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0de95698009, createdName=ms1000000847212667, createdTime=Thu May 09 17:46:13 CST 2024, time=2024-05-09, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2204148, encodeId=89c5220414846, content=请问各位老师这家接受非邀稿的综述吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=009a8811870, createdName=ms1000000556586108, createdTime=Sat May 11 20:56:37 CST 2024, time=2024-05-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2204018, encodeId=f930220401846, content=有人的editor是暨南大学何教授的吗？她申稿一般很慢吗？已经一周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sat May 11 07:59:44 CST 2024, time=2024-05-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2203518, encodeId=279b2203518d9, content=请问有遇到过editor assessment这一步开始邮件说是分配给主编，之后又分配给副主编的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Wed May 08 19:41:40 CST 2024, time=2024-05-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2190439, encodeId=ddf6219043910, content=想问一下各位大佬，最后投稿前生成的pdf里图片特别不清晰，但是下载下来又是清晰的，这应该怎么搞呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=737c9183844, createdName=ms2000002053337250, createdTime=Fri Mar 01 16:28:28 CST 2024, time=2024-03-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1237955, encodeId=4429123e9555f, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：中药药理;中药复方 经验分享：5.30投稿 5.31要求提供缩略词，补充后当晚提交了 6.6 under review 6.22 Required Reviews Completed 6.26 revise 主编+6个审稿专家，加起来50多个问题，审稿意见非常细节，很注重创新性。还好整体评价比较积极，对文章大框架没什么意见，只给了我3周修改，我还补了一点实验，最后几天写回复写到怀疑人生…… 7.14 summit 7.15 Under Editor Assessment 7.24 under review 8.2 Required Reviews Completed 8.3 Decision in Process 8.4 accepted 8.6 Proof 感谢主编和外审专家们！第一次投sci，好多地方都不清楚，每天都快把论坛翻烂了……还好最后顺利接收，写一点我在翻帖子时大家提问多的事情吧：1.Author Agreement：这个在爱思唯尔投稿作者须知那里有个链接能下载，有点不太好找。2.western结果：revise时要求提供原始未裁剪的膜，这个前期做实验的时候需要注意下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=feb46571516, createdName=msyukira, createdTime=Wed Aug 10 23:59:55 CST 2022, time=2022-08-10, status=1, ipAttribution=)]

2024-01-17 14621ac1m87(暂无昵称) 来自江苏省

偏重的研究方向：中药;心血管
经验分享：请问大家，投稿半个月，状态一直是Submitted to Journal，这种情况正常吗，需要发邮件问一下吗

27 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2204456, encodeId=69602204456e9, content=偏重的研究方向：天然产物;炎症 经验分享：2023.11投稿； 2024.02.03大修，五个审稿人，审稿人意见不多，编辑给了很多意见，给二十四天，补实验，申请延期一个月修回； 2023.03.26修回； 2023.05.08 decision in process 2023.05.09 accept 2023.05.11 proof. 从投稿到接收发表花了6个月，一审花了接近3个月，杂志要求严格，意见比较中肯，要求提供全膜WB条带（目的条带与内参出自同一条膜），中间因为一些琐事耽搁，2个月后修回，返修后编辑和审稿人效率很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67c06520855, createdName=ms8000001534909283, createdTime=Mon May 13 15:59:16 CST 2024, time=2024-05-13, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2182208, encodeId=314b21822083a, content=偏重的研究方向：中药;心血管 经验分享：请问大家，投稿半个月，状态一直是Submitted to Journal，这种情况正常吗，需要发邮件问一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad4c5114631, createdName=14621ac1m87(暂无昵称), createdTime=Wed Jan 17 15:56:01 CST 2024, time=2024-01-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2195245, encodeId=5a9d2195245ff, content=1.02投稿，现在还在under review...一点消息无。等的心焦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26465474991, createdName=ms2000000315947498, createdTime=Mon Mar 25 16:02:09 CST 2024, time=2024-03-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2177803, encodeId=19a121e7803be, content=让我修了两轮的格式和图片 12.25 submitted to journal 12.26 under editor assessment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240101/570c45f5d7f2451da2e0a51a7b25b479/824b9aa7cdc24982879c3db6cbeb3798.jpg, createdBy=a3422257516, createdName=samtol, createdTime=Thu Dec 28 15:41:53 CST 2023, time=2023-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2203719, encodeId=faec2203e1952, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：单体;药理;胃肠疾病 经验分享：怎么办呢，在编辑手里放了1个多月，现在变成Reviewer invited都十天了，怎么办啊，好想写催稿信，但是又不敢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0de95698009, createdName=ms1000000847212667, createdTime=Thu May 09 17:46:13 CST 2024, time=2024-05-09, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2204148, encodeId=89c5220414846, content=请问各位老师这家接受非邀稿的综述吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=009a8811870, createdName=ms1000000556586108, createdTime=Sat May 11 20:56:37 CST 2024, time=2024-05-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2204018, encodeId=f930220401846, content=有人的editor是暨南大学何教授的吗？她申稿一般很慢吗？已经一周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sat May 11 07:59:44 CST 2024, time=2024-05-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2203518, encodeId=279b2203518d9, content=请问有遇到过editor assessment这一步开始邮件说是分配给主编，之后又分配给副主编的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Wed May 08 19:41:40 CST 2024, time=2024-05-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2190439, encodeId=ddf6219043910, content=想问一下各位大佬，最后投稿前生成的pdf里图片特别不清晰，但是下载下来又是清晰的，这应该怎么搞呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=737c9183844, createdName=ms2000002053337250, createdTime=Fri Mar 01 16:28:28 CST 2024, time=2024-03-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1237955, encodeId=4429123e9555f, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：中药药理;中药复方 经验分享：5.30投稿 5.31要求提供缩略词，补充后当晚提交了 6.6 under review 6.22 Required Reviews Completed 6.26 revise 主编+6个审稿专家，加起来50多个问题，审稿意见非常细节，很注重创新性。还好整体评价比较积极，对文章大框架没什么意见，只给了我3周修改，我还补了一点实验，最后几天写回复写到怀疑人生…… 7.14 summit 7.15 Under Editor Assessment 7.24 under review 8.2 Required Reviews Completed 8.3 Decision in Process 8.4 accepted 8.6 Proof 感谢主编和外审专家们！第一次投sci，好多地方都不清楚，每天都快把论坛翻烂了……还好最后顺利接收，写一点我在翻帖子时大家提问多的事情吧：1.Author Agreement：这个在爱思唯尔投稿作者须知那里有个链接能下载，有点不太好找。2.western结果：revise时要求提供原始未裁剪的膜，这个前期做实验的时候需要注意下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=feb46571516, createdName=msyukira, createdTime=Wed Aug 10 23:59:55 CST 2022, time=2022-08-10, status=1, ipAttribution=)]

2024-03-25 ms2000000315947498 来自四川省

1.02投稿，现在还在under review...一点消息无。等的心焦

19 14

展开14条回复

[GetPortalCommentsPageByObjectIdResponse(id=2204456, encodeId=69602204456e9, content=偏重的研究方向：天然产物;炎症 经验分享：2023.11投稿； 2024.02.03大修，五个审稿人，审稿人意见不多，编辑给了很多意见，给二十四天，补实验，申请延期一个月修回； 2023.03.26修回； 2023.05.08 decision in process 2023.05.09 accept 2023.05.11 proof. 从投稿到接收发表花了6个月，一审花了接近3个月，杂志要求严格，意见比较中肯，要求提供全膜WB条带（目的条带与内参出自同一条膜），中间因为一些琐事耽搁，2个月后修回，返修后编辑和审稿人效率很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67c06520855, createdName=ms8000001534909283, createdTime=Mon May 13 15:59:16 CST 2024, time=2024-05-13, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2182208, encodeId=314b21822083a, content=偏重的研究方向：中药;心血管 经验分享：请问大家，投稿半个月，状态一直是Submitted to Journal，这种情况正常吗，需要发邮件问一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad4c5114631, createdName=14621ac1m87(暂无昵称), createdTime=Wed Jan 17 15:56:01 CST 2024, time=2024-01-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2195245, encodeId=5a9d2195245ff, content=1.02投稿，现在还在under review...一点消息无。等的心焦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26465474991, createdName=ms2000000315947498, createdTime=Mon Mar 25 16:02:09 CST 2024, time=2024-03-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2177803, encodeId=19a121e7803be, content=让我修了两轮的格式和图片 12.25 submitted to journal 12.26 under editor assessment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240101/570c45f5d7f2451da2e0a51a7b25b479/824b9aa7cdc24982879c3db6cbeb3798.jpg, createdBy=a3422257516, createdName=samtol, createdTime=Thu Dec 28 15:41:53 CST 2023, time=2023-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2203719, encodeId=faec2203e1952, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：单体;药理;胃肠疾病 经验分享：怎么办呢，在编辑手里放了1个多月，现在变成Reviewer invited都十天了，怎么办啊，好想写催稿信，但是又不敢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0de95698009, createdName=ms1000000847212667, createdTime=Thu May 09 17:46:13 CST 2024, time=2024-05-09, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2204148, encodeId=89c5220414846, content=请问各位老师这家接受非邀稿的综述吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=009a8811870, createdName=ms1000000556586108, createdTime=Sat May 11 20:56:37 CST 2024, time=2024-05-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2204018, encodeId=f930220401846, content=有人的editor是暨南大学何教授的吗？她申稿一般很慢吗？已经一周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sat May 11 07:59:44 CST 2024, time=2024-05-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2203518, encodeId=279b2203518d9, content=请问有遇到过editor assessment这一步开始邮件说是分配给主编，之后又分配给副主编的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Wed May 08 19:41:40 CST 2024, time=2024-05-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2190439, encodeId=ddf6219043910, content=想问一下各位大佬，最后投稿前生成的pdf里图片特别不清晰，但是下载下来又是清晰的，这应该怎么搞呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=737c9183844, createdName=ms2000002053337250, createdTime=Fri Mar 01 16:28:28 CST 2024, time=2024-03-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1237955, encodeId=4429123e9555f, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：中药药理;中药复方 经验分享：5.30投稿 5.31要求提供缩略词，补充后当晚提交了 6.6 under review 6.22 Required Reviews Completed 6.26 revise 主编+6个审稿专家，加起来50多个问题，审稿意见非常细节，很注重创新性。还好整体评价比较积极，对文章大框架没什么意见，只给了我3周修改，我还补了一点实验，最后几天写回复写到怀疑人生…… 7.14 summit 7.15 Under Editor Assessment 7.24 under review 8.2 Required Reviews Completed 8.3 Decision in Process 8.4 accepted 8.6 Proof 感谢主编和外审专家们！第一次投sci，好多地方都不清楚，每天都快把论坛翻烂了……还好最后顺利接收，写一点我在翻帖子时大家提问多的事情吧：1.Author Agreement：这个在爱思唯尔投稿作者须知那里有个链接能下载，有点不太好找。2.western结果：revise时要求提供原始未裁剪的膜，这个前期做实验的时候需要注意下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=feb46571516, createdName=msyukira, createdTime=Wed Aug 10 23:59:55 CST 2022, time=2022-08-10, status=1, ipAttribution=)]

2023-12-28 samtol 来自浙江省

让我修了两轮的格式和图片
12.25 submitted to journal
12.26 under editor assessment

42 32

展开32条回复

[GetPortalCommentsPageByObjectIdResponse(id=2204456, encodeId=69602204456e9, content=偏重的研究方向：天然产物;炎症 经验分享：2023.11投稿； 2024.02.03大修，五个审稿人，审稿人意见不多，编辑给了很多意见，给二十四天，补实验，申请延期一个月修回； 2023.03.26修回； 2023.05.08 decision in process 2023.05.09 accept 2023.05.11 proof. 从投稿到接收发表花了6个月，一审花了接近3个月，杂志要求严格，意见比较中肯，要求提供全膜WB条带（目的条带与内参出自同一条膜），中间因为一些琐事耽搁，2个月后修回，返修后编辑和审稿人效率很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67c06520855, createdName=ms8000001534909283, createdTime=Mon May 13 15:59:16 CST 2024, time=2024-05-13, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2182208, encodeId=314b21822083a, content=偏重的研究方向：中药;心血管 经验分享：请问大家，投稿半个月，状态一直是Submitted to Journal，这种情况正常吗，需要发邮件问一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad4c5114631, createdName=14621ac1m87(暂无昵称), createdTime=Wed Jan 17 15:56:01 CST 2024, time=2024-01-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2195245, encodeId=5a9d2195245ff, content=1.02投稿，现在还在under review...一点消息无。等的心焦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26465474991, createdName=ms2000000315947498, createdTime=Mon Mar 25 16:02:09 CST 2024, time=2024-03-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2177803, encodeId=19a121e7803be, content=让我修了两轮的格式和图片 12.25 submitted to journal 12.26 under editor assessment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240101/570c45f5d7f2451da2e0a51a7b25b479/824b9aa7cdc24982879c3db6cbeb3798.jpg, createdBy=a3422257516, createdName=samtol, createdTime=Thu Dec 28 15:41:53 CST 2023, time=2023-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2203719, encodeId=faec2203e1952, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：单体;药理;胃肠疾病 经验分享：怎么办呢，在编辑手里放了1个多月，现在变成Reviewer invited都十天了，怎么办啊，好想写催稿信，但是又不敢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0de95698009, createdName=ms1000000847212667, createdTime=Thu May 09 17:46:13 CST 2024, time=2024-05-09, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2204148, encodeId=89c5220414846, content=请问各位老师这家接受非邀稿的综述吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=009a8811870, createdName=ms1000000556586108, createdTime=Sat May 11 20:56:37 CST 2024, time=2024-05-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2204018, encodeId=f930220401846, content=有人的editor是暨南大学何教授的吗？她申稿一般很慢吗？已经一周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sat May 11 07:59:44 CST 2024, time=2024-05-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2203518, encodeId=279b2203518d9, content=请问有遇到过editor assessment这一步开始邮件说是分配给主编，之后又分配给副主编的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Wed May 08 19:41:40 CST 2024, time=2024-05-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2190439, encodeId=ddf6219043910, content=想问一下各位大佬，最后投稿前生成的pdf里图片特别不清晰，但是下载下来又是清晰的，这应该怎么搞呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=737c9183844, createdName=ms2000002053337250, createdTime=Fri Mar 01 16:28:28 CST 2024, time=2024-03-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1237955, encodeId=4429123e9555f, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：中药药理;中药复方 经验分享：5.30投稿 5.31要求提供缩略词，补充后当晚提交了 6.6 under review 6.22 Required Reviews Completed 6.26 revise 主编+6个审稿专家，加起来50多个问题，审稿意见非常细节，很注重创新性。还好整体评价比较积极，对文章大框架没什么意见，只给了我3周修改，我还补了一点实验，最后几天写回复写到怀疑人生…… 7.14 summit 7.15 Under Editor Assessment 7.24 under review 8.2 Required Reviews Completed 8.3 Decision in Process 8.4 accepted 8.6 Proof 感谢主编和外审专家们！第一次投sci，好多地方都不清楚，每天都快把论坛翻烂了……还好最后顺利接收，写一点我在翻帖子时大家提问多的事情吧：1.Author Agreement：这个在爱思唯尔投稿作者须知那里有个链接能下载，有点不太好找。2.western结果：revise时要求提供原始未裁剪的膜，这个前期做实验的时候需要注意下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=feb46571516, createdName=msyukira, createdTime=Wed Aug 10 23:59:55 CST 2022, time=2022-08-10, status=1, ipAttribution=)]

2024-05-09 ms1000000847212667 来自新疆

审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向：单体;药理;胃肠疾病
经验分享：怎么办呢，在编辑手里放了1个多月，现在变成Reviewer invited都十天了，怎么办啊，好想写催稿信，但是又不敢。

4 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2204456, encodeId=69602204456e9, content=偏重的研究方向：天然产物;炎症 经验分享：2023.11投稿； 2024.02.03大修，五个审稿人，审稿人意见不多，编辑给了很多意见，给二十四天，补实验，申请延期一个月修回； 2023.03.26修回； 2023.05.08 decision in process 2023.05.09 accept 2023.05.11 proof. 从投稿到接收发表花了6个月，一审花了接近3个月，杂志要求严格，意见比较中肯，要求提供全膜WB条带（目的条带与内参出自同一条膜），中间因为一些琐事耽搁，2个月后修回，返修后编辑和审稿人效率很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67c06520855, createdName=ms8000001534909283, createdTime=Mon May 13 15:59:16 CST 2024, time=2024-05-13, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2182208, encodeId=314b21822083a, content=偏重的研究方向：中药;心血管 经验分享：请问大家，投稿半个月，状态一直是Submitted to Journal，这种情况正常吗，需要发邮件问一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad4c5114631, createdName=14621ac1m87(暂无昵称), createdTime=Wed Jan 17 15:56:01 CST 2024, time=2024-01-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2195245, encodeId=5a9d2195245ff, content=1.02投稿，现在还在under review...一点消息无。等的心焦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26465474991, createdName=ms2000000315947498, createdTime=Mon Mar 25 16:02:09 CST 2024, time=2024-03-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2177803, encodeId=19a121e7803be, content=让我修了两轮的格式和图片 12.25 submitted to journal 12.26 under editor assessment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240101/570c45f5d7f2451da2e0a51a7b25b479/824b9aa7cdc24982879c3db6cbeb3798.jpg, createdBy=a3422257516, createdName=samtol, createdTime=Thu Dec 28 15:41:53 CST 2023, time=2023-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2203719, encodeId=faec2203e1952, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：单体;药理;胃肠疾病 经验分享：怎么办呢，在编辑手里放了1个多月，现在变成Reviewer invited都十天了，怎么办啊，好想写催稿信，但是又不敢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0de95698009, createdName=ms1000000847212667, createdTime=Thu May 09 17:46:13 CST 2024, time=2024-05-09, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2204148, encodeId=89c5220414846, content=请问各位老师这家接受非邀稿的综述吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=009a8811870, createdName=ms1000000556586108, createdTime=Sat May 11 20:56:37 CST 2024, time=2024-05-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2204018, encodeId=f930220401846, content=有人的editor是暨南大学何教授的吗？她申稿一般很慢吗？已经一周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sat May 11 07:59:44 CST 2024, time=2024-05-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2203518, encodeId=279b2203518d9, content=请问有遇到过editor assessment这一步开始邮件说是分配给主编，之后又分配给副主编的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Wed May 08 19:41:40 CST 2024, time=2024-05-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2190439, encodeId=ddf6219043910, content=想问一下各位大佬，最后投稿前生成的pdf里图片特别不清晰，但是下载下来又是清晰的，这应该怎么搞呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=737c9183844, createdName=ms2000002053337250, createdTime=Fri Mar 01 16:28:28 CST 2024, time=2024-03-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1237955, encodeId=4429123e9555f, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：中药药理;中药复方 经验分享：5.30投稿 5.31要求提供缩略词，补充后当晚提交了 6.6 under review 6.22 Required Reviews Completed 6.26 revise 主编+6个审稿专家，加起来50多个问题，审稿意见非常细节，很注重创新性。还好整体评价比较积极，对文章大框架没什么意见，只给了我3周修改，我还补了一点实验，最后几天写回复写到怀疑人生…… 7.14 summit 7.15 Under Editor Assessment 7.24 under review 8.2 Required Reviews Completed 8.3 Decision in Process 8.4 accepted 8.6 Proof 感谢主编和外审专家们！第一次投sci，好多地方都不清楚，每天都快把论坛翻烂了……还好最后顺利接收，写一点我在翻帖子时大家提问多的事情吧：1.Author Agreement：这个在爱思唯尔投稿作者须知那里有个链接能下载，有点不太好找。2.western结果：revise时要求提供原始未裁剪的膜，这个前期做实验的时候需要注意下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=feb46571516, createdName=msyukira, createdTime=Wed Aug 10 23:59:55 CST 2022, time=2022-08-10, status=1, ipAttribution=)]

2024-05-11 ms1000000556586108 来自湖南省

请问各位老师这家接受非邀稿的综述吗？

4 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2204456, encodeId=69602204456e9, content=偏重的研究方向：天然产物;炎症 经验分享：2023.11投稿； 2024.02.03大修，五个审稿人，审稿人意见不多，编辑给了很多意见，给二十四天，补实验，申请延期一个月修回； 2023.03.26修回； 2023.05.08 decision in process 2023.05.09 accept 2023.05.11 proof. 从投稿到接收发表花了6个月，一审花了接近3个月，杂志要求严格，意见比较中肯，要求提供全膜WB条带（目的条带与内参出自同一条膜），中间因为一些琐事耽搁，2个月后修回，返修后编辑和审稿人效率很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67c06520855, createdName=ms8000001534909283, createdTime=Mon May 13 15:59:16 CST 2024, time=2024-05-13, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2182208, encodeId=314b21822083a, content=偏重的研究方向：中药;心血管 经验分享：请问大家，投稿半个月，状态一直是Submitted to Journal，这种情况正常吗，需要发邮件问一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad4c5114631, createdName=14621ac1m87(暂无昵称), createdTime=Wed Jan 17 15:56:01 CST 2024, time=2024-01-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2195245, encodeId=5a9d2195245ff, content=1.02投稿，现在还在under review...一点消息无。等的心焦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26465474991, createdName=ms2000000315947498, createdTime=Mon Mar 25 16:02:09 CST 2024, time=2024-03-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2177803, encodeId=19a121e7803be, content=让我修了两轮的格式和图片 12.25 submitted to journal 12.26 under editor assessment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240101/570c45f5d7f2451da2e0a51a7b25b479/824b9aa7cdc24982879c3db6cbeb3798.jpg, createdBy=a3422257516, createdName=samtol, createdTime=Thu Dec 28 15:41:53 CST 2023, time=2023-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2203719, encodeId=faec2203e1952, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：单体;药理;胃肠疾病 经验分享：怎么办呢，在编辑手里放了1个多月，现在变成Reviewer invited都十天了，怎么办啊，好想写催稿信，但是又不敢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0de95698009, createdName=ms1000000847212667, createdTime=Thu May 09 17:46:13 CST 2024, time=2024-05-09, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2204148, encodeId=89c5220414846, content=请问各位老师这家接受非邀稿的综述吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=009a8811870, createdName=ms1000000556586108, createdTime=Sat May 11 20:56:37 CST 2024, time=2024-05-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2204018, encodeId=f930220401846, content=有人的editor是暨南大学何教授的吗？她申稿一般很慢吗？已经一周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sat May 11 07:59:44 CST 2024, time=2024-05-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2203518, encodeId=279b2203518d9, content=请问有遇到过editor assessment这一步开始邮件说是分配给主编，之后又分配给副主编的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Wed May 08 19:41:40 CST 2024, time=2024-05-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2190439, encodeId=ddf6219043910, content=想问一下各位大佬，最后投稿前生成的pdf里图片特别不清晰，但是下载下来又是清晰的，这应该怎么搞呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=737c9183844, createdName=ms2000002053337250, createdTime=Fri Mar 01 16:28:28 CST 2024, time=2024-03-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1237955, encodeId=4429123e9555f, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：中药药理;中药复方 经验分享：5.30投稿 5.31要求提供缩略词，补充后当晚提交了 6.6 under review 6.22 Required Reviews Completed 6.26 revise 主编+6个审稿专家，加起来50多个问题，审稿意见非常细节，很注重创新性。还好整体评价比较积极，对文章大框架没什么意见，只给了我3周修改，我还补了一点实验，最后几天写回复写到怀疑人生…… 7.14 summit 7.15 Under Editor Assessment 7.24 under review 8.2 Required Reviews Completed 8.3 Decision in Process 8.4 accepted 8.6 Proof 感谢主编和外审专家们！第一次投sci，好多地方都不清楚，每天都快把论坛翻烂了……还好最后顺利接收，写一点我在翻帖子时大家提问多的事情吧：1.Author Agreement：这个在爱思唯尔投稿作者须知那里有个链接能下载，有点不太好找。2.western结果：revise时要求提供原始未裁剪的膜，这个前期做实验的时候需要注意下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=feb46571516, createdName=msyukira, createdTime=Wed Aug 10 23:59:55 CST 2022, time=2022-08-10, status=1, ipAttribution=)]

2024-05-11 ms8000001555903844 来自北京

有人的editor是暨南大学何教授的吗？她申稿一般很慢吗？已经一周了

3 0

[GetPortalCommentsPageByObjectIdResponse(id=2204456, encodeId=69602204456e9, content=偏重的研究方向：天然产物;炎症 经验分享：2023.11投稿； 2024.02.03大修，五个审稿人，审稿人意见不多，编辑给了很多意见，给二十四天，补实验，申请延期一个月修回； 2023.03.26修回； 2023.05.08 decision in process 2023.05.09 accept 2023.05.11 proof. 从投稿到接收发表花了6个月，一审花了接近3个月，杂志要求严格，意见比较中肯，要求提供全膜WB条带（目的条带与内参出自同一条膜），中间因为一些琐事耽搁，2个月后修回，返修后编辑和审稿人效率很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67c06520855, createdName=ms8000001534909283, createdTime=Mon May 13 15:59:16 CST 2024, time=2024-05-13, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2182208, encodeId=314b21822083a, content=偏重的研究方向：中药;心血管 经验分享：请问大家，投稿半个月，状态一直是Submitted to Journal，这种情况正常吗，需要发邮件问一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad4c5114631, createdName=14621ac1m87(暂无昵称), createdTime=Wed Jan 17 15:56:01 CST 2024, time=2024-01-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2195245, encodeId=5a9d2195245ff, content=1.02投稿，现在还在under review...一点消息无。等的心焦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26465474991, createdName=ms2000000315947498, createdTime=Mon Mar 25 16:02:09 CST 2024, time=2024-03-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2177803, encodeId=19a121e7803be, content=让我修了两轮的格式和图片 12.25 submitted to journal 12.26 under editor assessment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240101/570c45f5d7f2451da2e0a51a7b25b479/824b9aa7cdc24982879c3db6cbeb3798.jpg, createdBy=a3422257516, createdName=samtol, createdTime=Thu Dec 28 15:41:53 CST 2023, time=2023-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2203719, encodeId=faec2203e1952, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：单体;药理;胃肠疾病 经验分享：怎么办呢，在编辑手里放了1个多月，现在变成Reviewer invited都十天了，怎么办啊，好想写催稿信，但是又不敢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0de95698009, createdName=ms1000000847212667, createdTime=Thu May 09 17:46:13 CST 2024, time=2024-05-09, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2204148, encodeId=89c5220414846, content=请问各位老师这家接受非邀稿的综述吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=009a8811870, createdName=ms1000000556586108, createdTime=Sat May 11 20:56:37 CST 2024, time=2024-05-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2204018, encodeId=f930220401846, content=有人的editor是暨南大学何教授的吗？她申稿一般很慢吗？已经一周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sat May 11 07:59:44 CST 2024, time=2024-05-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2203518, encodeId=279b2203518d9, content=请问有遇到过editor assessment这一步开始邮件说是分配给主编，之后又分配给副主编的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Wed May 08 19:41:40 CST 2024, time=2024-05-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2190439, encodeId=ddf6219043910, content=想问一下各位大佬，最后投稿前生成的pdf里图片特别不清晰，但是下载下来又是清晰的，这应该怎么搞呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=737c9183844, createdName=ms2000002053337250, createdTime=Fri Mar 01 16:28:28 CST 2024, time=2024-03-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1237955, encodeId=4429123e9555f, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：中药药理;中药复方 经验分享：5.30投稿 5.31要求提供缩略词，补充后当晚提交了 6.6 under review 6.22 Required Reviews Completed 6.26 revise 主编+6个审稿专家，加起来50多个问题，审稿意见非常细节，很注重创新性。还好整体评价比较积极，对文章大框架没什么意见，只给了我3周修改，我还补了一点实验，最后几天写回复写到怀疑人生…… 7.14 summit 7.15 Under Editor Assessment 7.24 under review 8.2 Required Reviews Completed 8.3 Decision in Process 8.4 accepted 8.6 Proof 感谢主编和外审专家们！第一次投sci，好多地方都不清楚，每天都快把论坛翻烂了……还好最后顺利接收，写一点我在翻帖子时大家提问多的事情吧：1.Author Agreement：这个在爱思唯尔投稿作者须知那里有个链接能下载，有点不太好找。2.western结果：revise时要求提供原始未裁剪的膜，这个前期做实验的时候需要注意下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=feb46571516, createdName=msyukira, createdTime=Wed Aug 10 23:59:55 CST 2022, time=2022-08-10, status=1, ipAttribution=)]

2024-05-08 ms8000001555903844 来自北京

请问有遇到过editor assessment这一步开始邮件说是分配给主编，之后又分配给副主编的吗

5 0

[GetPortalCommentsPageByObjectIdResponse(id=2204456, encodeId=69602204456e9, content=偏重的研究方向：天然产物;炎症 经验分享：2023.11投稿； 2024.02.03大修，五个审稿人，审稿人意见不多，编辑给了很多意见，给二十四天，补实验，申请延期一个月修回； 2023.03.26修回； 2023.05.08 decision in process 2023.05.09 accept 2023.05.11 proof. 从投稿到接收发表花了6个月，一审花了接近3个月，杂志要求严格，意见比较中肯，要求提供全膜WB条带（目的条带与内参出自同一条膜），中间因为一些琐事耽搁，2个月后修回，返修后编辑和审稿人效率很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67c06520855, createdName=ms8000001534909283, createdTime=Mon May 13 15:59:16 CST 2024, time=2024-05-13, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2182208, encodeId=314b21822083a, content=偏重的研究方向：中药;心血管 经验分享：请问大家，投稿半个月，状态一直是Submitted to Journal，这种情况正常吗，需要发邮件问一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad4c5114631, createdName=14621ac1m87(暂无昵称), createdTime=Wed Jan 17 15:56:01 CST 2024, time=2024-01-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2195245, encodeId=5a9d2195245ff, content=1.02投稿，现在还在under review...一点消息无。等的心焦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26465474991, createdName=ms2000000315947498, createdTime=Mon Mar 25 16:02:09 CST 2024, time=2024-03-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2177803, encodeId=19a121e7803be, content=让我修了两轮的格式和图片 12.25 submitted to journal 12.26 under editor assessment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240101/570c45f5d7f2451da2e0a51a7b25b479/824b9aa7cdc24982879c3db6cbeb3798.jpg, createdBy=a3422257516, createdName=samtol, createdTime=Thu Dec 28 15:41:53 CST 2023, time=2023-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2203719, encodeId=faec2203e1952, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：单体;药理;胃肠疾病 经验分享：怎么办呢，在编辑手里放了1个多月，现在变成Reviewer invited都十天了，怎么办啊，好想写催稿信，但是又不敢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0de95698009, createdName=ms1000000847212667, createdTime=Thu May 09 17:46:13 CST 2024, time=2024-05-09, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2204148, encodeId=89c5220414846, content=请问各位老师这家接受非邀稿的综述吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=009a8811870, createdName=ms1000000556586108, createdTime=Sat May 11 20:56:37 CST 2024, time=2024-05-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2204018, encodeId=f930220401846, content=有人的editor是暨南大学何教授的吗？她申稿一般很慢吗？已经一周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sat May 11 07:59:44 CST 2024, time=2024-05-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2203518, encodeId=279b2203518d9, content=请问有遇到过editor assessment这一步开始邮件说是分配给主编，之后又分配给副主编的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Wed May 08 19:41:40 CST 2024, time=2024-05-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2190439, encodeId=ddf6219043910, content=想问一下各位大佬，最后投稿前生成的pdf里图片特别不清晰，但是下载下来又是清晰的，这应该怎么搞呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=737c9183844, createdName=ms2000002053337250, createdTime=Fri Mar 01 16:28:28 CST 2024, time=2024-03-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1237955, encodeId=4429123e9555f, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：中药药理;中药复方 经验分享：5.30投稿 5.31要求提供缩略词，补充后当晚提交了 6.6 under review 6.22 Required Reviews Completed 6.26 revise 主编+6个审稿专家，加起来50多个问题，审稿意见非常细节，很注重创新性。还好整体评价比较积极，对文章大框架没什么意见，只给了我3周修改，我还补了一点实验，最后几天写回复写到怀疑人生…… 7.14 summit 7.15 Under Editor Assessment 7.24 under review 8.2 Required Reviews Completed 8.3 Decision in Process 8.4 accepted 8.6 Proof 感谢主编和外审专家们！第一次投sci，好多地方都不清楚，每天都快把论坛翻烂了……还好最后顺利接收，写一点我在翻帖子时大家提问多的事情吧：1.Author Agreement：这个在爱思唯尔投稿作者须知那里有个链接能下载，有点不太好找。2.western结果：revise时要求提供原始未裁剪的膜，这个前期做实验的时候需要注意下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=feb46571516, createdName=msyukira, createdTime=Wed Aug 10 23:59:55 CST 2022, time=2022-08-10, status=1, ipAttribution=)]

2024-03-01 ms2000002053337250 来自辽宁省

想问一下各位大佬，最后投稿前生成的pdf里图片特别不清晰，但是下载下来又是清晰的，这应该怎么搞呀

24 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2204456, encodeId=69602204456e9, content=偏重的研究方向：天然产物;炎症 经验分享：2023.11投稿； 2024.02.03大修，五个审稿人，审稿人意见不多，编辑给了很多意见，给二十四天，补实验，申请延期一个月修回； 2023.03.26修回； 2023.05.08 decision in process 2023.05.09 accept 2023.05.11 proof. 从投稿到接收发表花了6个月，一审花了接近3个月，杂志要求严格，意见比较中肯，要求提供全膜WB条带（目的条带与内参出自同一条膜），中间因为一些琐事耽搁，2个月后修回，返修后编辑和审稿人效率很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67c06520855, createdName=ms8000001534909283, createdTime=Mon May 13 15:59:16 CST 2024, time=2024-05-13, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2182208, encodeId=314b21822083a, content=偏重的研究方向：中药;心血管 经验分享：请问大家，投稿半个月，状态一直是Submitted to Journal，这种情况正常吗，需要发邮件问一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad4c5114631, createdName=14621ac1m87(暂无昵称), createdTime=Wed Jan 17 15:56:01 CST 2024, time=2024-01-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2195245, encodeId=5a9d2195245ff, content=1.02投稿，现在还在under review...一点消息无。等的心焦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26465474991, createdName=ms2000000315947498, createdTime=Mon Mar 25 16:02:09 CST 2024, time=2024-03-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2177803, encodeId=19a121e7803be, content=让我修了两轮的格式和图片 12.25 submitted to journal 12.26 under editor assessment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240101/570c45f5d7f2451da2e0a51a7b25b479/824b9aa7cdc24982879c3db6cbeb3798.jpg, createdBy=a3422257516, createdName=samtol, createdTime=Thu Dec 28 15:41:53 CST 2023, time=2023-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2203719, encodeId=faec2203e1952, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：单体;药理;胃肠疾病 经验分享：怎么办呢，在编辑手里放了1个多月，现在变成Reviewer invited都十天了，怎么办啊，好想写催稿信，但是又不敢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0de95698009, createdName=ms1000000847212667, createdTime=Thu May 09 17:46:13 CST 2024, time=2024-05-09, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2204148, encodeId=89c5220414846, content=请问各位老师这家接受非邀稿的综述吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=009a8811870, createdName=ms1000000556586108, createdTime=Sat May 11 20:56:37 CST 2024, time=2024-05-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2204018, encodeId=f930220401846, content=有人的editor是暨南大学何教授的吗？她申稿一般很慢吗？已经一周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sat May 11 07:59:44 CST 2024, time=2024-05-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2203518, encodeId=279b2203518d9, content=请问有遇到过editor assessment这一步开始邮件说是分配给主编，之后又分配给副主编的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Wed May 08 19:41:40 CST 2024, time=2024-05-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2190439, encodeId=ddf6219043910, content=想问一下各位大佬，最后投稿前生成的pdf里图片特别不清晰，但是下载下来又是清晰的，这应该怎么搞呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=737c9183844, createdName=ms2000002053337250, createdTime=Fri Mar 01 16:28:28 CST 2024, time=2024-03-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1237955, encodeId=4429123e9555f, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：中药药理;中药复方 经验分享：5.30投稿 5.31要求提供缩略词，补充后当晚提交了 6.6 under review 6.22 Required Reviews Completed 6.26 revise 主编+6个审稿专家，加起来50多个问题，审稿意见非常细节，很注重创新性。还好整体评价比较积极，对文章大框架没什么意见，只给了我3周修改，我还补了一点实验，最后几天写回复写到怀疑人生…… 7.14 summit 7.15 Under Editor Assessment 7.24 under review 8.2 Required Reviews Completed 8.3 Decision in Process 8.4 accepted 8.6 Proof 感谢主编和外审专家们！第一次投sci，好多地方都不清楚，每天都快把论坛翻烂了……还好最后顺利接收，写一点我在翻帖子时大家提问多的事情吧：1.Author Agreement：这个在爱思唯尔投稿作者须知那里有个链接能下载，有点不太好找。2.western结果：revise时要求提供原始未裁剪的膜，这个前期做实验的时候需要注意下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=feb46571516, createdName=msyukira, createdTime=Wed Aug 10 23:59:55 CST 2022, time=2022-08-10, status=1, ipAttribution=)]

2022-08-10 msyukira

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：中药药理;中药复方
经验分享：5.30投稿
5.31要求提供缩略词，补充后当晚提交了
6.6 under review
6.22 Required Reviews Completed
6.26 revise
主编+6个审稿专家，加起来50多个问题，审稿意见非常细节，很注重创新性。还好整体评价比较积极，对文章大框架没什么意见，只给了我3周修改，我还补了一点实验，最后几天写回复写到怀疑人生……
7.14 summit
7.15 Under Editor Assessment
7.24 under review
8.2 Required Reviews Completed
8.3 Decision in Process
8.4 accepted
8.6 Proof

感谢主编和外审专家们！第一次投sci，好多地方都不清楚，每天都快把论坛翻烂了……还好最后顺利接收，写一点我在翻帖子时大家提问多的事情吧：1.Author Agreement：这个在爱思唯尔投稿作者须知那里有个链接能下载，有点不太好找。2.western结果：revise时要求提供原始未裁剪的膜，这个前期做实验的时候需要注意下

61 8

展开8条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务